|
FOXJ3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.656100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.766500E-02 |
| Normal-vs-Stage2 |
7.462200E-01 |
| Normal-vs-Stage3 |
2.145000E-01 |
| Normal-vs-Stage4 |
3.583400E-01 |
| Stage1-vs-Stage2 |
4.413200E-01 |
| Stage1-vs-Stage3 |
8.968400E-01 |
| Stage1-vs-Stage4 |
9.999400E-01 |
| Stage2-vs-Stage3 |
4.294600E-01 |
| Stage2-vs-Stage4 |
4.756000E-01 |
| Stage3-vs-Stage4 |
9.292800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.420700E-03 |
| Normal-vs-AfricanAmerican |
5.294600E-01 |
| Normal-vs-Asian |
2.829900E-04 |
| Caucasian-vs-AfricanAmerican |
6.872800E-01 |
| Caucasian-vs-Asian |
9.825500E-02 |
| AfricanAmerican-vs-Asian |
1.464000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.980700E-03 |
| Normal-vs-Female |
6.279800E-01 |
| Male-vs-Female |
2.319600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.711600E-01 |
| Normal-vs-Extreme_Weight |
1.103640E-01 |
| Normal-vs-Obese |
3.147600E-02 |
| Normal-vs-Extreme_Obese |
8.951500E-04 |
| Normal_Weight-vs-Extreme_Weight |
6.876000E-01 |
| Normal_Weight-vs-Obese |
7.076400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.542600E-01 |
| Extreme_Weight-vs-Obese |
9.588000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.447400E-01 |
| Obese-vs-Extreme_Obese |
3.231400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.581700E-02 |
| Normal-vs-Age(41-60Yrs) |
5.161600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.984100E-03 |
| Normal-vs-Age(81-100Yrs) |
5.67209999968732E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.582400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.250400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.625800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.480640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.075800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.531800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.50785999999403E-05 |
| Normal-VS-Type2 PRCC |
3.603200E-01 |
| Normal-VS-KIRP CIMP |
1.695020E-01 |
| Normal-VS-Unclassified PRCC |
2.146200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.615400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.882800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.159200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.852400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.805600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.204800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.582600E-01 |
| Normal-vs-N1 |
3.080600E-01 |
| Normal-vs-N2 |
6.013200E-01 |
| N0-vs-N1 |
7.561600E-01 |
| N0-vs-N2 |
9.145000E-01 |
| N1-vs-N2 |
9.992000E-01 |
|
|
